The IASLC is collecting member and patient experiences with COVID-19 as a way to pool knowledge and connect our members during this public health crisis. These stories, information from the Journal of Thoracic Oncology (JTO), and official statements from the IASLC will be published on this page. In addition, this page will feature links to important resources such as journal articles and social media groups relevant to the care of patients with lung cancer.

If you would like to share a video or written statement about your personal interactions, concerns, guidance and hopes, please send your submission via email to Instructions about how to transfer video files will be supplied as requested.

With so many uncertainties regarding resources and the unknown aspects of how COVID affects patients with lung cancer, IASLC members offer perspectives on some of the most timely questions about daily practice.

Pertinent Questions Regarding the Care of Patients with Lung Cancer in the COVID-19 Environment 

Dr. Brendon Stiles—USA

Dr. Stiles is an Associate Professor of Cardiothoracic Surgery at Weill Cornell Medicine (@WeillCornell) and a thoracic surgeon at NewYork-Presbyterian/Weill Cornell Medical Center (@nyphospital). He is vice-chair of the IASLC Communications Committee and extremely active on Twitter (@BrendonStilesMD).

New York City has been hit hard by the pandemic. A lot of what we see on the news in the U.S. has to do with equipment shortages, but Dr. Brendon Stiles sends us some optimistic news from the heart of the city. Read his full story.

Dr. Anand Sachithanandan—Kuala Lumpur

Dr. Anand Sachithanandan is a consultant cardiothoracic surgeon in private practice in greater Kuala Lumpur. He is co-founder and president of Lung Cancer Network Malaysia, an NGO that aims to improve outcomes from lung cancer through awareness, advocacy and education. Offering a comprehensive portrait of the effects of COVID-19 both on his work and daily life in Malaysia, Dr. Anand describes his efforts to mitigate risk to patients and colleagues, preserve kindness and hope, and ultimately continue to provide life-saving cancer treatment in an unprecedented health care landscape. Read his full story.

Dr. Narjust Duma—USA

Dr. Narjust Duma is a member of the UW Carbone Cancer Center and Assistant Professor of Medicine in the Division of Hematology, Medical Oncology, and Palliative Care. She graduated first in her medical school class at La Universidad Catolica Nordestana in the Dominican Republic. She then completed her internal medicine residency at Rutgers University-New Jersey Medical School, where she was awarded the most scholarly resident award in 2015 and 2016. Dr. Duma completed her hematology and medical oncology fellowship at Mayo Clinic Rochester and was selected by her peers as one of the 2018-2019 chief hematology and medical oncology fellows.

From patients who are worried about being passed over for life-saving treatment to physicians who are missing the valuable coping measures that tangible interactions provide, Dr. Duma describes the weight the pandemic has placed on her and those for whom she cares. Read her full article.

Janet Freeman-Daily—USA

Janet is a retired aerospace systems engineer, freelance writer, and metastatic lung cancer patient/activist. Diagnosed in 2011, her focus is now on translating the experience and science of lung cancer for others. She serves as a research advocate for two NCCN facilities, the NCI and other government agencies, and as an Editorial Group member for the IASLC Lung Cancer News. She has collaborated on research and education projects with lung cancer nonprofits, published research papers and science articles, and cofounded #LCSM Chat, the ROS1ders, and Hope with Answers.

Read about Janet’s experience as a lung cancer survivor with a cough in Washington during the early days of the COVID-19 outbreak. This article was originally published in Slate.

The newest episode of Lung Cancer Considered, the IASLC’s official podcast program, focuses on the impact of the COVID-19 epidemic on lung cancer patients and healthcare providers. This episode features Janet Freeman-Daily—writer, lung cancer patient, advocate and Twitter chat moderator of the Lung Cancer Social Media chat (#LCSMchat). Janet is joined by Dr. Amy Moore, Director of Science and Research at the Go2 Foundation, Dr. Upal Basu Roy, Vice President of Research at LUNGevity Foundation, and Dr. Lecia Sequist, Director of Center for Innovation and Early Cancer Detection at Massachusetts General Hospital and the Landry Family Associate Professor of Medicine at Harvard Medical School.


It is not easy to find a cohesive collection of relevant journal articles and rapidly changing guidelines about COVID-19 in relation to patients with cancer. Erin M. Bange, MD, is a first-year oncology fellow at Penn Medicine, a diverse clinical and research entity of the University of Pennsylvania. Dr. Bange has assembled oncology-specific information into a helpful document, which IASLC will be posting as updated every few days.

View the PDF Supplemental Information

Quick Reference

IASLC 2020 World Conference on Lung Cancer 2020 Postponed

Considering the latest updates on the Coronavirus (COVID-19) outbreak and after careful consideration of the current situation, the IASLC Board of Directors and leadership have made the decision to postpone the IASLC 2020 World Conference on Lung Cancer (WCLC 2020), which was scheduled to take place August 9 – 12, 2020 in Singapore. At this time, the World Conference on Lung Cancer has been rescheduled to January 26 – 29, 2021 in Singapore (WCLC 2020 Singapore)


The postponement was based on multiple factors, including the current travel restrictions put in place by Singapore, the U.S. and other countries, and, importantly, the toll currently being placed on our health care community. These restrictions significantly affect the ability of delegates, speakers, presenters and exhibitors to participate fully in the WCLC 2020. This decision also underlines our commitment to containing the virus and preventing further sickness and loss of life, as per WHO recommendations. We recognize that many people have already contributed a great deal of time and energy into helping prepare for this event, and we share this sense of disappointment.  


Given the postponement, we will transfer your registration to the event in January 2021, at no cost. Should you be unable to join us in January 2021, your registration fee will be refunded. Cancellations received by June 1, 2020 will be refunded fully. Cancellations received after June 1, 2020 may be subject to the standard cancellation policy.  


The WCLC has always provided a platform for sharing cutting-edge research and creating space for new collaborations and partnerships. Considering the postponement, we will further evaluate the WCLC 2020 Singapore scientific program due to the recent global pandemic. We are also exploring the possibility of a virtual Presidential Symposium in August in order to engage and bring you new, relevant late-breaking science. Additionally, if you have submitted an abstract for WCLC 2020 Singapore, visit to learn about the options available and ensure your research is submitted to this premier conference. Abstract submission will remain open until August 28, 2020.


The IASLC represents a large community of medical professionals, many of whom are now working increased hours to support cancer patients and those impacted by the COVID-19 virus. Our thoughts and best wishes go out to these individuals, their families and their patients. 


The health, safety and security of all participants and staff at IASLC events is of the utmost importance to us. We will continue to monitor the situation and provide updates regarding future IASLC events and activities.   


For any questions, please contact the IASLC offices at


Dave Mesko, MBA

Tetsuya Mitsudomi, MD, PhD
IASLC President

Thursday, March 26, 19:00 ET (23:00 GMT): multi-cancer

Friday, March 27, 20:00 ET, 24:00 GMT: thoracic oncology

Saturday, March 28, 10:00 am ET (14:00 GMT): thoracic oncology